ロード中...
Staphylococcus aureus FabI: Inhibition, Substrate Recognition and Potential Implications for In Vivo Essentiality
Methicillin-resistant Staphylococcus aureus (MRSA) infections constitute a serious health threat worldwide, and novel antibiotics are therefore urgently needed. The enoyl-ACP reductase (saFabI) is essential for the S. aureus fatty acid biosynthesis and, hence, serves as an attractive drug target. We...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2012
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3376755/ https://ncbi.nlm.nih.gov/pubmed/22579249 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.str.2012.03.013 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|